Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma

被引:4
|
作者
Huang, Hui [1 ]
Liu, Jie [1 ]
Wang, Xiaolei [1 ]
Liu, Shaoyan [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Head & Neck Surg Oncol, Beijing, Peoples R China
来源
关键词
thyroid nodules; thyroid cancer; papillary carcinoma; thyroidectomy; active surveillance; NATURAL-HISTORY; CANCER; RISK; MICROCARCINOMA; PREVALENCE; VOLUME;
D O I
10.3389/fendo.2022.941080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo observe the outcomes of nonsuspicious contralateral nodules with active surveillance in patients with papillary thyroid carcinoma (PTC). Methods4pt?>Consecutive patients who underwent lobectomy for PTC were retrospectively reviewed. Patients with one or more nodules with nonsuspicious ultrasonography (US) features in the contralateral lobe were included. ResultsTwo hundred and eighty-three patients were included. All patients underwent thyroid lobectomy with ipsilateral prophylactic central neck dissection. A total of 123 patients (43.5%) were classified as ATA low-risk, and 160 patients (56.5%) were classified as intermediate-risk. The median size of the contralateral nodules was 3 mm (range, 2 to 16 mm). After a period of follow-up, the median size change of contralateral nodules was 0 mm (range, -7 to 8 mm). Eight patients (2.8%) had nodule growth >3 mm, 223 patients (78.8%) had stable or decreased nodules, and 52 patients (18.4%) had no detectable nodules. Nodules in 24 patients had suspicious US features, 16 of which were diagnosed with PTMC by either cytology after FNA (in 7 patients) or histopathology after completion thyroidectomy (in 9 patients). Another four patients received completion thyroidectomy for ipsilateral cervical lymph node metastasis. The 5-year residual lobe recurrence (RLR) rate and recurrence-free survival (RFS) rate were 7.4% and 89.8%, respectively. Multivariate analysis showed that multifocality and ATA intermediate-risk were independent predictors for RLR (HR4.083, 95%CI 1.480-11.261, P = 0.007; HR 6.045, 95%CI 1.370-26.662, P = 0.017, respectively) and RFS (HR 5.240, 95%CI 2.114-12.991, P < 0.001; HR 5.223, 95%CI 1.353-17.765, P = 0.008, respectively). ConclusionsActive surveillance for nonsuspicious contralateral nodules in patients with low-risk and selected intermediate-risk PTC is safe. Multifocality and ATA intermediate-risk are predicters for recurrence. Early detection and salvage surgery are effective.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma
    Ritter, Amit
    Bachar, Gideon
    Hirsch, Dania
    Benbassat, Carlos
    Katz, Orna
    Kochen, Nadav
    Diker-Cohen, Talia
    Akirov, Amit
    Shimon, Ilan
    Robenshtok, Eyal
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02): : 407 - 414
  • [2] Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound
    Xu, Siyuan
    Huang, Hui
    Xian, Keyao
    Wang, Xiaolei
    Xu, Zhengang
    Liu, Shaoyan
    Liu, Jie
    ENDOCRINE, 2024, 86 (01) : 276 - 283
  • [3] Contralateral Low-to-Intermediate Suspicion Nodule is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma
    Pak, Shin Jeong
    Kwon, Douk
    Kim, Byung-Chang
    Cho, Jae Won
    Kim, Won Woong
    Lee, Yu-mi
    Sung, Tae-Yon
    Baek, Jung Hwan
    Kim, Won Gu
    Kim, Won Bae
    Chung, Ki-Wook
    THYROID, 2023, 33 (11) : 1339 - 1348
  • [4] Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma
    Park, Young Min
    Lee, Doh Young
    Oh, Kyung Ho
    Cho, Jae-Gu
    Baek, Seung-Kuk
    Kwon, Soon-Young
    Jung, Kwang-Yoon
    Woo, Jeong-Soo
    ORAL ONCOLOGY, 2017, 75 : 1 - 5
  • [5] Long-Term Outcomes After Lobectomy for Patients with High-Risk Papillary Thyroid Carcinoma
    Iwao Sugitani
    Hiroko Kazusaka
    Aya Ebina
    Wataru Shimbashi
    Kazuhisa Toda
    Kengo Takeuchi
    World Journal of Surgery, 2023, 47 : 382 - 391
  • [6] Long-Term Outcomes After Lobectomy for Patients with High-Risk Papillary Thyroid Carcinoma
    Sugitani, Iwao
    Kazusaka, Hiroko
    Ebina, Aya
    Shimbashi, Wataru
    Toda, Kazuhisa
    Takeuchi, Kengo
    WORLD JOURNAL OF SURGERY, 2023, 47 (02) : 382 - 391
  • [7] Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules
    Chen, Min -Long
    Xu, Dong
    Yan, Xing-Qiang
    Xie, Bo-Jian
    ASIAN JOURNAL OF SURGERY, 2023, 46 (01) : 156 - 159
  • [8] Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?
    Ma, Tengfei
    Wang, Haiyang
    Liu, Jifeng
    Zou, Jian
    Liu, Shixi
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [9] Analysis of patterns and risk factors regarding the onset of nodules in the contralateral thyroid lobe during follow-up ultrasonography among patients after unilateral lobectomy for the treatment of papillary thyroid carcinoma
    Sun, Chao
    Wang, Qian
    Guo, Qianqian
    Chang, Qing
    Liang, Xin
    Wang, Dong
    Dai, Hongbin
    Hu, Zhiguang
    Xu, Tianyu
    Feng, Wenqi
    Li, Zhengjiang
    Niu, Lijuan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (05): : 819 - 827
  • [10] Optimal Serum Thyrotropin Level for Patients with Papillary Thyroid Carcinoma After Lobectomy
    Xu, Siyuan
    Huang, Ying
    Huang, Hui
    Zhang, Xiaohang
    Qian, Jiaxin
    Wang, Xiaolei
    Xu, Zhengang
    Liu, Shaoyan
    Liu, Jie
    THYROID, 2022, 32 (02) : 138 - 144